⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iv chronic lymphocytic leukemia

Every month we try and update this database with for stage iv chronic lymphocytic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)NCT00947388
Recurrent Small...
Refractory Chro...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Bendamustine Hy...
Alemtuzumab
18 Years - Case Comprehensive Cancer Center
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative DiseaseNCT00176475
Leukemia
Lymphoma
Multiple Myelom...
rituximab
therapeutic all...
18 Years - Rutgers, The State University of New Jersey
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic LeukemiaNCT00769522
Chronic Lymphoc...
Rituximab
Bendamustine
Cyclophosphamid...
Fludarabine
18 Years - German CLL Study Group
CD19-Specific T-cells in Treating Patients With Advanced Lymphoid MalignanciesNCT02529813
Acute Biphenoty...
Acute Lymphobla...
Blasts 5 Percen...
CD19 Positive
Minimal Residua...
Non-Hodgkin Lym...
Small Lymphocyt...
Stage III Chron...
Stage IV Chroni...
Cyclophosphamid...
Fludarabine Pho...
Laboratory Biom...
Tisagenlecleuce...
1 Year - 80 YearsM.D. Anderson Cancer Center
Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic LeukemiaNCT00276809
Chronic Lymphoc...
alemtuzumab
filgrastim
carmustine
cyclophosphamid...
cytarabine
dexamethasone
etoposide
fludarabine pho...
melphalan
autologous bone...
peripheral bloo...
radiation thera...
18 Years - 60 YearsGerman CLL Study Group
High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaNCT00002788
Leukemia
filgrastim
cyclophosphamid...
dexamethasone
etoposide
peripheral bloo...
radiation thera...
17 Years - 65 YearsFred Hutchinson Cancer Center
Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic LeukemiaNCT01271283
Chronic Lymphoc...
Stage III Chron...
Stage IV Chroni...
Diagnostic Labo...
Lenalidomide
18 Years - National Cancer Institute (NCI)
Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell TransplantNCT00833534
Leukemia
Lymphoma
rituximab
lenalidomide
18 Years - Fred Hutchinson Cancer Center
Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic LeukemiaNCT00278213
Prolymphocytic ...
alemtuzumab
cyclophosphamid...
fludarabine pho...
mitoxantrone hy...
18 Years - 70 YearsGerman CLL Study Group
Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's LymphomaNCT00278161
Leukemia
Lymphoma
Pegfilgrastim
Rituximab
Cyclophosphamid...
18 Years - 70 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Denileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaNCT00026429
Leukemia
Lymphoma
denileukin dift...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic LeukemiaNCT00002838
Leukemia
Filgrastim (G-C...
Cyclophosphamid...
Fludarabine Pho...
Peripheral Bloo...
- 65 YearsM.D. Anderson Cancer Center
Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaNCT00612612
B-cell Chronic ...
Leukemia
Prolymphocytic ...
Refractory Chro...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
obatoclax mesyl...
fludarabine pho...
rituximab
laboratory biom...
18 Years - National Cancer Institute (NCI)
Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line TherapyNCT02649387
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
Ibrutinib
Laboratory Biom...
18 Years - Mayo Clinic
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)NCT00005626
Leukemia
Lymphoma
Irinotecan
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersNCT00003572
Leukemia
Lymphoma
Multiple Myelom...
Myelodysplastic...
peripheral bloo...
mycophenolate m...
tacrolimus
allogeneic bone...
radiation thera...
18 Years - 70 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell TransplantNCT00833534
Leukemia
Lymphoma
rituximab
lenalidomide
18 Years - Fred Hutchinson Cancer Center
Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid CancerNCT00248430
Graft Versus Ho...
Leukemia
Lymphoma
Multiple Myelom...
aldesleukin
therapeutic all...
melphalan
bone marrow abl...
peripheral bloo...
18 Years - 69 YearsFred Hutchinson Cancer Center
Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationNCT00005641
Chronic Myelopr...
Graft Versus Ho...
Leukemia
Multiple Myelom...
Myelodysplastic...
anti-thymocyte ...
busulfan
cyclophosphamid...
cyclosporine
leucovorin calc...
methotrexate
methylprednisol...
allogeneic bone...
in vitro-treate...
radiation thera...
15 Years - 60 YearsH. Lee Moffitt Cancer Center and Research Institute
Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaNCT00003174
Leukemia
bryostatin 1
cladribine
18 Years - Barbara Ann Karmanos Cancer Institute
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT00918723
Chronic Lymphoc...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Fludarabine Pho...
Cyclophosphamid...
Rituximab
Vorinostat
18 Years - Fred Hutchinson Cancer Center
Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaNCT00003829
Leukemia
cyclophosphamid...
fludarabine pho...
18 Years - Alliance for Clinical Trials in Oncology
UCN-01 in Treating Patients With Advanced CancerNCT00003289
Leukemia
Lymphoma
Unspecified Adu...
7-hydroxystauro...
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerNCT00296023
Chronic Myelopr...
Leukemia
Lymphoma
Multiple Myelom...
Myelodysplastic...
anti-thymocyte ...
filgrastim
therapeutic all...
busulfan
fludarabine pho...
methotrexate
tacrolimus
nonmyeloablativ...
peripheral bloo...
18 Years - 75 YearsUniversity of California, San Francisco
CD19-Specific T-cells in Treating Patients With Advanced Lymphoid MalignanciesNCT02529813
Acute Biphenoty...
Acute Lymphobla...
Blasts 5 Percen...
CD19 Positive
Minimal Residua...
Non-Hodgkin Lym...
Small Lymphocyt...
Stage III Chron...
Stage IV Chroni...
Cyclophosphamid...
Fludarabine Pho...
Laboratory Biom...
Tisagenlecleuce...
1 Year - 80 YearsM.D. Anderson Cancer Center
PS-341 in Treating Patients With Advanced CancerNCT00006362
Leukemia
Lymphoma
Multiple Myelom...
Precancerous Co...
Unspecified Adu...
bortezomib
18 Years - Mayo Clinic
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By ChemotherapyNCT00003341
Anemia
Leukemia
Lymphoma
Multiple Myelom...
epoetin alfa
quality-of-life...
18 Years - Memorial Sloan Kettering Cancer Center
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic CancerNCT00782379
Leukemia
Lymphoma
Myelodysplastic...
busulfan
cyclophosphamid...
fludarabine pho...
mycophenolate m...
tacrolimus
allogeneic hema...
peripheral bloo...
18 Years - 60 YearsNorthside Hospital, Inc.
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaNCT00551239
Leukemia
Lymphoma
rituximab
fludarabine pho...
pixantrone dima...
18 Years - 120 YearsCTI BioPharma
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic LeukemiaNCT00602459
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
Cyclophosphamid...
Fludarabine Pho...
Laboratory Biom...
Lenalidomide
Rituximab
18 Years - National Cancer Institute (NCI)
Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological CancersNCT01240525
Graft Versus Ho...
Leukemia
Lymphoma
Myeloma
Myelodysplastic...
CD4 DLI
No DLI
18 Years - 69 YearsUniversity College, London
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic LeukemiaNCT00769522
Chronic Lymphoc...
Rituximab
Bendamustine
Cyclophosphamid...
Fludarabine
18 Years - German CLL Study Group
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic CancerNCT00031980
Anemia
Leukemia
Neutropenia
Thrombocytopeni...
cyclosporine
18 Years - Alliance for Clinical Trials in Oncology
Tipifarnib in Treating Patients With Advanced Hematologic CancerNCT00005967
Chronic Myelopr...
Leukemia
Lymphoma
Multiple Myelom...
Myelodysplastic...
tipifarnib
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic LeukemiaNCT00002838
Leukemia
Filgrastim (G-C...
Cyclophosphamid...
Fludarabine Pho...
Peripheral Bloo...
- 65 YearsM.D. Anderson Cancer Center
Denileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaNCT00026429
Leukemia
Lymphoma
denileukin dift...
18 Years - National Cancer Institute (NCI)
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT00918723
Chronic Lymphoc...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Fludarabine Pho...
Cyclophosphamid...
Rituximab
Vorinostat
18 Years - Fred Hutchinson Cancer Center
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaNCT00541034
Leukemia
Lymphoma
rituximab
cyclophosphamid...
pentostatin
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic LeukemiaNCT01361711
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
alemtuzumab
ofatumumab
biopsy
18 Years - Northwestern University
Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's LymphomaNCT00387959
Leukemia
Lymphoma
filgrastim
rituximab
cyclophosphamid...
cyclosporine
fludarabine pho...
mycophenolate m...
allogeneic hema...
umbilical cord ...
total-body irra...
18 Years - 70 YearsMemorial Sloan Kettering Cancer Center
Fludarabine in Treating Patients With Chronic Lymphocytic LeukemiaNCT00049075
Leukemia
fludarabine pho...
16 Years - 120 YearsCanadian Cancer Trials Group
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaNCT01886872
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
Bendamustine Hy...
Ibrutinib
Laboratory Biom...
Quality-of-Life...
Rituximab
65 Years - National Cancer Institute (NCI)
UCN-01 in Treating Patients With Advanced CancerNCT00003289
Leukemia
Lymphoma
Unspecified Adu...
7-hydroxystauro...
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic CancerNCT00031980
Anemia
Leukemia
Neutropenia
Thrombocytopeni...
cyclosporine
18 Years - Alliance for Clinical Trials in Oncology
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based TherapyNCT01145469
Leukemia
DNA analysis
gene expression...
polymorphism an...
laboratory biom...
medical chart r...
18 Years - 120 YearsEastern Cooperative Oncology Group
Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT01024010
Chronic Lymphoc...
Stage 0 Chronic...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Cyclophosphamid...
Laboratory Biom...
Ofatumumab
Pentostatin
18 Years - Mayo Clinic
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or LeukemiaNCT00004084
Leukemia
Lymphoma
indium In 111 L...
yttrium Y 90 ep...
18 Years - Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)NCT00309881
Chronic Lymphoc...
rituximab
cyclophosphamid...
doxorubicin hyd...
prednisone
vincristine sul...
18 Years - German CLL Study Group
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic LeukemiaNCT00003764
Leukemia
cyclophosphamid...
fludarabine pho...
18 Years - 120 YearsEastern Cooperative Oncology Group
Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic LeukemiaNCT00003659
Leukemia
filgrastim
rituximab
cyclophosphamid...
fludarabine pho...
18 Years - 75 YearsMemorial Sloan Kettering Cancer Center
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerNCT00004061
Leukemia
Lymphoma
Oral Complicati...
filgrastim
palifermin
cyclophosphamid...
etoposide
ifosfamide
peripheral bloo...
quality-of-life...
radiation thera...
18 Years - 65 YearsNational Cancer Institute (NCI)
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerNCT00004061
Leukemia
Lymphoma
Oral Complicati...
filgrastim
palifermin
cyclophosphamid...
etoposide
ifosfamide
peripheral bloo...
quality-of-life...
radiation thera...
18 Years - 65 YearsNational Cancer Institute (NCI)
Azadirachta Indica in Treating Patients With Chronic Lymphocytic LeukemiaNCT01251250
Refractory Chro...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
laboratory biom...
western blottin...
gene expression...
pharmacological...
flow cytometry
fluorescence in...
azadirachta ind...
reverse transcr...
18 Years - Roswell Park Cancer Institute
Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaNCT00026351
Leukemia
Lymphoma
rituximab
pentostatin
18 Years - National Cancer Institute (NCI)
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7NCT00812669
Leukemia
pegfilgrastim
rituximab
cyclophosphamid...
fludarabine pho...
cytogenetic ana...
fluorescence in...
gene expression...
mutation analys...
protein express...
flow cytometry
laboratory biom...
0 Years - 64 YearsCancer Trials Ireland
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic LeukemiaNCT00281892
Chronic Lymphoc...
Anemia
Fludarabine plu...
Fludarabine mon...
- German CLL Study Group
Flavopiridol in Treating Patients With Chronic Lymphocytic LeukemiaNCT00003620
B-cell Chronic ...
Refractory Chro...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
alvocidib
laboratory biom...
18 Years - National Cancer Institute (NCI)
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic LeukemiaNCT00769522
Chronic Lymphoc...
Rituximab
Bendamustine
Cyclophosphamid...
Fludarabine
18 Years - German CLL Study Group
Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous FludarabineNCT00274976
Leukemia
alemtuzumab
18 Years - 65 YearsNational Cancer Institute (NCI)
Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic LeukemiaNCT00017108
Leukemia
chlorambucil
cyclophosphamid...
fludarabine pho...
18 Years - 75 YearsNational Cancer Institute (NCI)
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)NCT00309881
Chronic Lymphoc...
rituximab
cyclophosphamid...
doxorubicin hyd...
prednisone
vincristine sul...
18 Years - German CLL Study Group
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT01027000
Leukemia
Lymphoma
rituximab
busulfan
cyclophosphamid...
fludarabine pho...
methotrexate
sirolimus
tacrolimus
allogeneic stem...
18 Years - 69 YearsAlliance for Clinical Trials in Oncology
Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's MacroglobulinemiaNCT00281983
Chronic Lymphoc...
alemtuzumab
anti-thymocyte ...
filgrastim
rituximab
therapeutic all...
busulfan
cyclophosphamid...
cyclosporine
fludarabine pho...
methotrexate
mycophenolate m...
peripheral bloo...
radiation thera...
18 Years - 65 YearsGerman CLL Study Group
Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT01076556
Chronic Lymphoc...
Prolymphocytic ...
Recurrent Small...
Refractory Chro...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Alvocidib Hydro...
Cyclophosphamid...
Diagnostic Labo...
Pharmacological...
Rituximab
18 Years - National Cancer Institute (NCI)
Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaNCT00006390
Leukemia
alemtuzumab
filgrastim
cyclophosphamid...
peripheral bloo...
radiation thera...
18 Years - 65 YearsEastern Cooperative Oncology Group
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaNCT00551239
Leukemia
Lymphoma
rituximab
fludarabine pho...
pixantrone dima...
18 Years - 120 YearsCTI BioPharma
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic LymphomaNCT00049413
Leukemia
Lymphoma
rituximab
cyclophosphamid...
pentostatin
18 Years - Hoag Memorial Hospital Presbyterian
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic LeukemiaNCT00275015
Chronic Lymphoc...
filgrastim
carmustine
cyclophosphamid...
cytarabine
dexamethasone
etoposide
fludarabine pho...
melphalan
bone marrow abl...
peripheral bloo...
radiation thera...
18 Years - 60 YearsGerman CLL Study Group
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete RemissionNCT00458523
Leukemia
alemtuzumab
fluorescence in...
mutation analys...
flow cytometry
18 Years - National Cancer Institute (NCI)
A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and MelphalanNCT00577278
Graft Versus Ho...
Leukemia
Lymphoma
rituximab
fludarabine pho...
melphalan
sirolimus
tacrolimus
allogeneic hema...
indium In 111 i...
yttrium Y 90 ib...
laboratory biom...
18 Years - 69 YearsCity of Hope Medical Center
Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLLNCT00072007
Leukemia
filgrastim
rituximab
CHOP regimen
cladribine
cyclophosphamid...
doxorubicin hyd...
prednisone
vincristine sul...
18 Years - 65 YearsSwiss Group for Clinical Cancer Research
Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaNCT00098670
B-cell Chronic ...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
alemtuzumab
rituximab
fludarabine pho...
18 Years - National Cancer Institute (NCI)
Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaNCT00006390
Leukemia
alemtuzumab
filgrastim
cyclophosphamid...
peripheral bloo...
radiation thera...
18 Years - 65 YearsEastern Cooperative Oncology Group
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell LymphomasNCT02213913
Adult Grade III...
B-cell Chronic ...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Cutaneous B-cel...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Progressive Hai...
Small Intestine...
Splenic Margina...
Stage 0 Chronic...
Stage I Adult D...
Stage I Adult D...
Stage I Adult D...
Stage I Adult H...
Stage I Adult I...
Stage I Chronic...
Stage I Grade 1...
Stage I Grade 2...
Stage I Grade 3...
Stage I Mantle ...
Stage I Margina...
Stage I Small L...
Stage II Adult ...
Stage II Chroni...
Stage II Small ...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Chron...
Stage III Grade...
Stage III Grade...
Stage III Grade...
Stage III Mantl...
Stage III Margi...
Stage III Small...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Chroni...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Mantle...
Stage IV Margin...
Stage IV Small ...
Testicular Lymp...
Untreated Hairy...
Waldenström Mac...
lenalidomide
etoposide
prednisone
vincristine sul...
doxorubicin hyd...
cyclophosphamid...
rituximab
quality-of-life...
laboratory biom...
18 Years - University of Chicago
Dasatinib in Treating Patients With Chronic Lymphocytic LeukemiaNCT01441882
Refractory Chro...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
Dasatinib
Laboratory Biom...
Pharmacological...
18 Years - OHSU Knight Cancer Institute
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT00602836
Leukemia
Lymphoma
Rituximab
Cyclophosphamid...
Lenalidomide
Pentostatin
18 Years - 120 YearsMayo Clinic
Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic LeukemiaNCT00265915
Leukemia
rituximab
sargramostim
15 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic LeukemiaNCT00462332
Leukemia
Fludarabine
Campath
Transplant
Campath
Fludarabine
Campath
Campath
- 60 YearsGruppo Italiano Malattie EMatologiche dell'Adulto
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic CancerNCT00004132
Drug/Agent Toxi...
Leukemia
Lymphoma
Multiple Myelom...
Oral Complicati...
Radiation Toxic...
filgrastim
palifermin
cyclophosphamid...
etoposide
ifosfamide
quality-of-life...
radiation thera...
12 Years - 65 YearsNational Cancer Institute (NCI)
Denileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaNCT00026429
Leukemia
Lymphoma
denileukin dift...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: